IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing

Journal of Investigative Dermatology

Volumn 136, Issue 2, 2016, Pages 487-496

  Rak, Gregory D ^a   Osborne, Lisa C ^b   Siracusa, Mark C ^a   Kim, Brian S ^a   Wang, Kelvin ^a   Bayat, Ardeshir ^c,d   Artis, David ^b   Volk, Susan W ^e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 33; INTERLEUKIN 5; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 3;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMOEPIDERMAL JUNCTION; EPITHELIZATION; FEMALE; GENE DELETION; GRANULATION TISSUE; GROUP 2 INNATE LYMPHOID CELL; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN EPITHELIUM; SKIN INJURY; WOUND CLOSURE; WOUND HEALING; ANIMAL; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INJURIES; INJURY; INNATE IMMUNITY; LYMPHOCYTE; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; PHYSIOLOGY; SKIN;

ANIMALS; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-33; LYMPHOCYTES; MICE; MICE, INBRED C57BL; SKIN; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84973633011     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/JID.2015.406     Document Type: Article

References (71)

1. Allen, J.E., Wynn, T.A., Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog, 7, 2011, e1002003.
2. Artis, D., Spits, H., The biology of innate lymphoid cells. Nature 517 (2015), 293–301.
3. Bjorkstrom, N.K., Kekalainen, E., Mjosberg, J., Tissue-specific effector functions of innate lymphoid cells. Immunology 139 (2013), 416–427.
4. Chang, Y.J., Kim, H.Y., Albacker, L.A., et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 12 (2011), 631–638.
5. Chen, L., Mehta, N.D., Zhao, Y., et al. Absence of CD4 or CD8 lymphocytes changes infiltration of inflammatory cells and profiles of cytokine expression in skin wounds, but does not impair healing. Exp Dermatol 23 (2014), 189–194.
6. Chen, L., Schrementi, M.E., Ranzer, M.J., et al. Blockade of mast cell activation reduces cutaneous scar formation. PLoS One, 9, 2014, e85226.
7. Dardenne, A.D., Wulff, B.C., Wilgus, T.A., The alarmin HMGB-1 influences healing outcomes in fetal skin wounds. Wound Repair Regen 21 (2013), 282–291.
8. Dovi, J.V., He, L.K., DiPietro, L.A., Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 73 (2003), 448–455.
9. Eming, S.A., Hammerschmidt, M., Krieg, T., et al. Interrelation of immunity and tissue repair or regeneration. Semin Cell Dev Biol 20 (2009), 517–527.
10. Eming, S.A., Martin, P., Tomic-Canic, M., Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med, 6, 2014, 265sr6.
11. Galiano, R.D., Michaels, Jt, Dobryansky, M., et al. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 12 (2004), 485–492.
12. Gause, W.C., Wynn, T.A., Allen, J.E., Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat Rev Immunol 13 (2013), 607–614.
13. Goldberg, S.R., Diegelmann, R.F., Wound healing primer. Surg Clin North Am 90 (2010), 1133–1146.
14. Greaves, N.S., Ashcroft, K.J., Baguneid, M., et al. Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing. J Dermatol Sci 72 (2013), 206–217.
15. Humbles, A.A., Lloyd, C.M., McMillan, S.J., et al. A critical role for eosinophils in allergic airways remodeling. Science 305 (2004), 1776–1779.
16. Imai, Y., Yasuda, K., Sakaguchi, Y., et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci USA 110 (2013), 13921–13926.
17. Kim, B.S., Siracusa, M.C., Saenz, S.A., et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med, 5, 2013, 170ra16.
18. Kim, B.S., Wang, K., Siracusa, M.C., et al. Basophils promote innate lymphoid cell responses in inflamed skin. J Immunol 193 (2014), 3717–3725.
19. Klose, C.S., Flach, M., Mohle, L., et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157 (2014), 340–356.
20. Koh, T.J., DiPietro, L.A., Inflammation and wound healing: The role of the macrophage. Expert Rev Mol Med, 13, 2011, e23.
21. Koumas, L., Smith, T.J., Feldon, S., et al. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol 163 (2003), 1291–1300.
22. Kuroiwa, K., Arai, T., Okazaki, H., et al. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Commun 284 (2001), 1104–1108.
23. Lai, Y., Li, D., Li, C., et al. The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury. Immunity 37 (2012), 74–84.
24. Lee, J.S., Seppanen, E., Patel, J., et al. ST2 receptor invalidation maintains wound inflammation, delays healing and increases fibrosis [e-pub ahead of print]. Exp Dermatol, 2015.
25. Lee, M.J., Shin, J.O., Jung, H.S., Thy-1 knockdown retards wound repair in mouse skin. J Dermatol Sci 69 (2013), 95–104.
26. Leitch, V.D., Strudwick, X.L., Matthaei, K.I., et al. IL-5-overexpressing mice exhibit eosinophilia and altered wound healing through mechanisms involving prolonged inflammation. Immunol Cell Biol 87 (2009), 131–140.
27. Li, J., Razumilava, N., Gores, G.J., et al. Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J Clin Invest 124 (2014), 3241–3251.
28. Lucas, T., Waisman, A., Ranjan, R., et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol 184 (2010), 3964–3977.
29. Luzina, I.G., Kopach, P., Lockatell, V., et al. Interleukin-33 potentiates bleomycin-induced lung injury. Am J Respir Cell Mol Biol 49 (2013), 999–1008.
30. Manetti, M., Ibba-Manneschi, L., Liakouli, V., et al. The IL1-like cytokine IL33 and its receptor are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Ann Rheum Dis 69 (2010), 598–605.
31. Mantovani, A., Biswas, S.K., Galdiero, M.R., et al. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229 (2013), 176–185.
32. Marvie, P., Lisbonne, M., L'Helgoualc'h, A., et al. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med 14 (2010), 1726–1739.
33. McHedlidze, T., Waldner, M., Zopf, S., et al. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 39 (2013), 357–371.
34. Miller, A.M., Asquith, D.L., Hueber, A.J., et al. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res 107 (2010), 650–658.
35. Mirza, R., DiPietro, L.A., Koh, T.J., Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 175 (2009), 2454–2462.
36. Mjosberg, J.M., Trifari, S., Crellin, N.K., et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12 (2011), 1055–1062.
37. Molofsky, A.B., Nussbaum, J.C., Liang, H.E., et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med 210 (2013), 535–549.
38. Monticelli, L.A., Sonnenberg, G.F., Abt, M.C., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12 (2011), 1045–1054.
39. Moro, K., Yamada, T., Tanabe, M., et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463 (2010), 540–544.
40. Nakamura, Y., Muguruma, Y., Yahata, T., et al. Expression of CD90 on keratinocyte stem/progenitor cells. Br J Dermatol 154 (2006), 1062–1070.
41. Neill, D.R., Wong, S.H., Bellosi, A., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464 (2010), 1367–1370.
42. Novak, M.L., Koh, T.J., Macrophage phenotypes during tissue repair. J Leukoc Biol 93 (2013), 875–881.
43. Nussbaum, J.C., Van Dyken, S.J., von Moltke, J., et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502 (2013), 245–248.
44. Oriente, A., Fedarko, N.S., Pacocha, S.E., et al. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther 292 (2000), 988–994.
45. Peters, T., Sindrilaru, A., Hinz, B., et al. Wound-healing defect of CD18(−/−) mice due to a decrease in TGF-beta1 and myofibroblast differentiation. EMBO J 24 (2005), 3400–3410.
46. Price, A.E., Liang, H.E., Sullivan, B.M., et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 107 (2010), 11489–11494.
47. Rankin, A.L., Mumm, J.B., Murphy, E., et al. IL-33 induces IL-13-dependent cutaneous fibrosis. J Immunol 184 (2010), 1526–1535.
48. Roediger, B., Kyle, R., Yip, K.H., et al. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat Immunol 14 (2013), 564–573.
49. Salimi, M., Barlow, J.L., Saunders, S.P., et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210 (2013), 2939–2950.
50. Schmidt, M., Gutknecht, D., Simon, J.C., et al. Controlling the balance of fibroblast proliferation and differentiation: Impact of Thy-1. J Invest Dermatol 135 (2015), 1893–1902.
51. Sebastian, A., Iqbal, S.A., Colthurst, J., et al. Electrical stimulation enhances epidermal proliferation in human cutaneous wounds by modulating p53-SIVA1 interaction. J Invest Dermatol 135 (2015), 1166–1174.
52. Sen, C.K., Gordillo, G.M., Roy, S., et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 17 (2009), 763–771.
53. Shih, B., Garside, E., McGrouther, D.A., et al. Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen 18 (2010), 139–153.
54. Shih, B., Sultan, M.J., Chaudhry, I.H., et al. Identification of biomarkers in sequential biopsies of patients with chronic wounds receiving simultaneous acute wounds: a genetic, histological, and noninvasive imaging study. Wound Repair Regen 20 (2012), 757–769.
55. Sindrilaru, A., Peters, T., Wieschalka, S., et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 121 (2011), 985–997.
56. Spits, H., Artis, D., Colonna, M., et al. Innate lymphoid cells—a proposal for uniform nomenclature. Nat Rev Immunol 13 (2013), 145–149.
57. Spits, H., Cupedo, T., Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 30 (2012), 647–675.
58. Taverna, D., Pollins, A.C., Sindona, G., et al. Imaging mass spectrometry for assessing cutaneous wound healing: analysis of pressure ulcers. J Proteome Res 14 (2015), 986–996.
59. Todd, R., Donoff, B.R., Chiang, T., et al. The eosinophil as a cellular source of transforming growth factor alpha in healing cutaneous wounds. Am J Pathol 138 (1991), 1307–1313.
60. Volk, S.W., Radu, A., Zhang, L., et al. Stromal progenitor cell therapy corrects the wound-healing defect in the ischemic rabbit ear model of chronic wound repair. Wound Repair Regen 15 (2007), 736–747.
61. Volk, S.W., Wang, Y., Mauldin, E.A., et al. Diminished type III collagen promotes myofibroblast differentiation and increases scar deposition in cutaneous wound healing. Cells Tissues Organs 194 (2011), 25–37.
62. Walker, J.A., McKenzie, A.N., Development and function of group 2 innate lymphoid cells. Curr Opin Immunol 25 (2013), 148–155.
63. Wilgus, T.A., Immune cells in the healing skin wound: influential players at each stage of repair. Pharmacol Res 58 (2008), 112–116.
64. Wulff, B.C., Parent, A.E., Meleski, M.A., et al. Mast cells contribute to scar formation during fetal wound healing. J Invest Dermatol 132 (2012), 458–465.
65. Wynn, T.A., IL-13 effector functions. Annu Rev Immunol 21 (2003), 425–456.
66. Wynn, T.A., Integrating mechanisms of pulmonary fibrosis. J Exp Med 208 (2011), 1339–1350.
67. Yanaba, K., Yoshizaki, A., Asano, Y., et al. Serum IL-33 levels are raised in patients with systemic sclerosis: Association with extent of skin sclerosis and severity of pulmonary fibrosis. Clin Rheumatol 30 (2011), 825–830.
68. Yang, J., Torio, A., Donoff, R.B., et al. Depletion of eosinophil infiltration by anti-IL-5 monoclonal antibody (TRFK-5) accelerates open skin wound epithelial closure. Am J Pathol 151 (1997), 813–819.
69. Yin, H., Li, X., Hu, S., et al. IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages. Mol Immunol 56 (2013), 347–353.
70. Yin, H., Li, X., Hu, S., et al. IL-33 promotes Staphylococcus aureus-infected wound healing in mice. Int Immunopharmacol 17 (2013), 432–438.
71. Zheng, T., Oh, M.H., Oh, S.Y., et al. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. J Invest Dermatol 129 (2009), 742–751.